William F. Doyle - 03 Mar 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Executive Chairman, Director
Signature
By: /s/ Steven Robbins, Attorney in fact for William F. Doyle
Issuer symbol
NVCR
Transactions as of
03 Mar 2022
Net transactions value
+$1,175,083
Form type
4
Filing time
07 Mar 2022, 17:21:15 UTC
Previous filing
02 Dec 2021
Next filing
09 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Award $1,175,083 +14,581 $80.59 14,581 03 Mar 2022 Ordinary Shares 14,581 $80.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options to buy 14,581 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.